Patient Experience: Real-life Comparisons and Testimonials Unlike other GLP-1 agonists that require daily administration, semaglutide can be taken once a week, making it more convenient for patients
Comorbid conditions like type 2 diabetes, hypertension, or metabolic syndrome often extend the recommended duration of GLP-1 therapy, as these conditions benefit from the medication's glucose-lowering and cardiovascular effects beyond weight loss alone
The first randomized, double-blind, placebo-controlled trial using liraglutide after MBS was performed by Lofton et al
Titration plan: use gradual dose escalation to reduce gastrointestinal side effects
Other initial symptoms include: angina pectoris, syncope, or lower extremity edema